Kasei Builds US Footprint with US$1.3 B Veloxis Buy
By Michelle Liu
Pharma Deals Review: Vol 2019 Issue 11 (Table of Contents)
Published: 28 Nov-2019
DOI: 10.3833/pdr.v2019.i11.2473 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Asahi Kasei Pharma Denmark, a subsidiary of Asahi Kasei Corporation, has agreed to acquire Veloxis Pharmaceuticals in a deal worth DKK8...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018